IINN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Inspira Technologies Oxy BHN Ltd (IINN) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company's financial health is weak, with widening net losses, declining liquidity, and missed revenue expectations. Technical indicators and trading trends also do not support a bullish outlook, and there are no strong proprietary trading signals to suggest a buy opportunity. Given the lack of positive catalysts and significant risks, it is recommended to avoid this stock.
The technical indicators suggest a bearish trend. The MACD is slightly positive but contracting, the RSI is neutral at 21.812, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with S1 at 0.513 and S2 at 0.486, indicating further downside potential.
The company treated its first patient using the ART100 system in April 2025, marking a milestone in clinical validation. Additionally, Inspira secured binding purchase orders totaling $49.5 million in mid-2025, indicating some initial commercial success.
The company reported FY 2025 revenue of only $0.3 million, missing expectations. R&D expenses increased significantly without translating into revenue, and the net loss widened to $13.22 million. Liquidity is a concern, with cash and cash equivalents decreasing to $3.159 million. The stock price has also declined significantly, with a regular market change of -4.37%.
In FY 2025, the company reported $0.3 million in revenue, missing expectations. R&D expenses rose to $7.496 million, and the net loss widened to $13.22 million. Liquidity is a concern, with cash and cash equivalents decreasing to $3.159 million as of December 31, 2025. For Q4 2023, revenue remained at 0, net income was -$3.008 million, and EPS was -0.24, showing no improvement YoY.
No recent analyst rating or price target changes available. Hedge funds and insiders are neutral, with no significant trading trends over the last quarter or month.
